Ellen G. Harrer

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

3D Virtual Reality Performance Metrics as a Future Fatigue Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

3D Virtual Reality Performance Metrics as a Future Fatigue Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Journal: Biomedicines
Published: January 25, 2026

Increased human herpesvirus-8 neutralizing response during remission from Kaposi's sarcoma.

Increased human herpesvirus-8 neutralizing response during remission from Kaposi's sarcoma.

Journal: The Journal of general virology
Published: November 20, 2024

Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1.

Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1.

Journal: iScience
Published: August 03, 2024

Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection.

Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection.

Journal: Nature communications
Published: April 25, 2024

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine.

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine.

Journal: Infection
Published: March 08, 2023

Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.

Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.

Journal: Viruses
Published: January 04, 2023

Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy.

Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy.

Journal: Vaccines
Published: January 02, 2023

Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection.

Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection.

Journal: Viruses
Published: January 25, 2022

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.

Journal: Frontiers in immunology
Published: November 09, 2020

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

Journal: PloS one
Published: March 12, 2018

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

Journal: AIDS (London, England)
Published: June 04, 2016

Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation.

Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation.

Journal: Chemical science
Published: December 13, 2015
Showing 1-12 of 16

Last Updated: 09/26/2026